IDEXX Laboratories Earnings Preview
Portfolio Pulse from Benzinga Insights
IDEXX Laboratories (NASDAQ:IDXX) is scheduled to release its quarterly earnings report on February 5, 2024, with analysts estimating an EPS of $2.11. Historical data shows that IDEXX's stock price reacts positively to earnings beats and guidance. Last quarter, IDEXX beat the EPS estimate by $0.16, leading to a 6.09% increase in its share price. Over the last year, IDXX shares have risen by 8.76%, indicating a bullish sentiment among long-term shareholders.
February 02, 2024 | 4:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
IDEXX Laboratories is expected to report an EPS of $2.11 for the upcoming quarter. Historical performance suggests a positive stock price reaction to earnings beats and guidance.
Given IDEXX Laboratories' history of outperforming EPS estimates and the subsequent positive stock price reactions, there is a strong likelihood of a positive short-term impact on IDXX's stock price if the company beats the EPS estimate again and provides positive guidance. The historical data provided shows a clear pattern of stock price increases following earnings beats, suggesting investor confidence in the company's performance.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100